Drug Database
Back to search

Spain· ES:89696

VALOMINDO 160 MG/1,5 MG COMPRIMIDOS DE LIBERACION MODIFICADA

A medicinal product containing valsartán + indapamida, registered in Spain by Krka D.D. Novo Mesto.

Checked against AEMPS CIMA (Spain) on

Informational only — not a medical device.

SOURCE REGISTER · ESAEMPS CIMA (Spain)normalisedVALOMINDO 160 MG/1,5 MG COMPRIMIDOS D…ATC—REGISTER NO.ES:89696PACKS LISTED0CHECKEDJune 3, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about valsartán + indapamidaAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

AEMPS CIMA (Spain)
Active substance
valsartán + indapamida
Manufacturer
Krka D.D. Novo Mesto
Country
Spain (ES)
ATC code
—
Reimbursed
Not published by this register
Source register
AEMPS CIMA (Spain)
Last checked
June 3, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Valsartán + indapamida in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All valsartán + indapamida products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Austria · Valsartan/Indapamid Tad
  • Bulgaria · Валоминдо, Валсартан/Индапамид Билев
  • Cyprus · Valomindo
  • Czechia · Vabinxo, Valsartan/Indapamid Krka
  • Germany · Valsainda Apontis, Vamipino
  • Estonia · Vabinxo, Yndivan
  • Finland · Valomindo
  • Greece · Valomindo
  • Croatia · Valomindo
  • Hungary · Norsiten, Vabincor
  • Lithuania · Vabinxo
  • Latvia · Vabinxo, Yndivan
  • Poland · Vabinxo, Yndivan
  • Portugal · Valomindo
  • Romania · Valomindo, Yndivan
  • Slovenia · Valomindo
  • Slovakia · Vabinxo, Yndivan

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/67b7b08c-494f-485d-ad56-d11f15546b7a
GET /v1/drugs/67b7b08c-494f-485d-ad56-d11f15546b7a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Medicamento Sujeto A Prescripción Médica",
  "estado": "{\"aut\":1720792141000}",
  "nregistro": "89696",
  "substance": "valsartán + indapamida"
}
API referenceMCP serverPlans

See everything about valsartán + indapamida.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console